 Vancomycin
"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
| Descriptor ID |
D014640
|
| MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
| Concept/Terms |
AB-Vancomycin- AB-Vancomycin
- curasan Brand of Vancomycin Hydrochloride
Diatracin- Diatracin
- Dista Brand of Vancomycin Hydrochloride
VANCO-cell- VANCO-cell
- cell pharm Brand of Vancomycin Hydrochloride
Vanco-saar- Vanco-saar
- MIP Brand of Vancomycin Hydrochloride
Vancocin- Vancocin
- Eli Lilly Brand of Vancomycin Hydrochloride
- Vancomycin Lilly
- Lilly Brand of Vancomycin Hydrochloride
- Vancocine
- Vancocin HCl
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in UAMS Profiles by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 | | 2021 | 2 | 2 | 4 | | 2020 | 2 | 1 | 3 | | 2019 | 1 | 1 | 2 | | 2018 | 2 | 0 | 2 | | 2017 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2015 | 2 | 0 | 2 | | 2014 | 1 | 1 | 2 | | 2012 | 1 | 0 | 1 | | 2011 | 0 | 4 | 4 | | 2010 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2004 | 2 | 0 | 2 | | 1996 | 1 | 0 | 1 | | 1990 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles over the past ten years.
-
Challa L, Villani MC, Hachem AA, Ma Y, Jo C, Patel K, Firmani S, Copley LA. Mitigating Risk of Acute Kidney Injury Among Children With Methicillin-resistant Staphylococcus aureus Osteomyelitis. J Pediatr Orthop. 2025 Feb 01; 45(2):e172-e178.
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
-
McAlpine A, Robinson JL, Barton M, Balamohan A, Davies HD, Skar G, Lefebvre MA, Almadani A, Freire D, Le Saux N, Bowes J, Srigley JA, Passarelli P, Bradley J, Khan S, Purewal R, Viel-Th?riault I, Ranger A, Hawkes MT. Cerebrospinal Fluid Shunt Infections: A Multicenter Pediatric Study. Pediatr Infect Dis J. 2022 06 01; 41(6):449-454.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rodvold KA, Maples HD. Questions on Vancomycin Dosing. Clin Infect Dis. 2021 10 05; 73(7):e1777-e1778.
-
Hoover A, Zimmerman JAO, Wiese S, Modi A. Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e1010-e1014.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Beringer AW, Rodvold KA, Maples HD. Validity of 2020 vancomycin consensus recommendations and further guidance for practical application. Am J Health Syst Pharm. 2021 07 22; 78(15):1364-1367.
-
Jarugula P, Scott S, Ivaturi V, Noack A, Moffett BS, Bhutta A, Gobburu JVS. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
-
Harrison ZL, Pace LR, Brown MN, Beenken KE, Smeltzer MS, Bumgardner JD, Haggard WO, Amber Jennings J. Staphylococcal infection prevention using antibiotic-loaded mannitol-chitosan paste in a?rabbit model of implant-associated osteomyelitis. J Orthop Res. 2021 11; 39(11):2455-2464.
-
Traversa A, Hammond DA, Peksa GD, DeMott JM. Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients. J Pharm Pract. 2021 Dec; 34(6):882-887.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020 04; 40(4):363-367.
-
Shah KJ, Cherabuddi K, Pressly KB, Wright KL, Shukla A. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges. BMC Nephrol. 2020 03 04; 21(1):76.
-
Basco MDS, Kothari A, McKinzie PB, Revollo JR, Agnihothram S, Azevedo MP, Saccente M, Hart ME. Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy. J Med Microbiol. 2019 Jun; 68(6):848-859.
-
Meeker DG, Cooper KB, Renard RL, Mears SC, Smeltzer MS, Barnes CL. Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement. J Arthroplasty. 2019 07; 34(7):1458-1461.
-
Velez JCQ, Obadan NO, Kaushal A, Alzubaidi M, Bhasin B, Sachdev SH, Karakala N, Arthur JM, Nesbit RM, Phadke GM. Vancomycin-Associated Acute Kidney Injury with a Steep Rise in Serum Creatinine. Nephron. 2018; 139(2):131-142.
-
Boles LR, Awais R, Beenken KE, Smeltzer MS, Haggard WO, Jessica AJ. Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm. Mil Med. 2018 03 01; 183(suppl_1):459-465.
-
Njoku JC, Van Schooneveld TC, Rupp ME, Olsen KM, Qiu F, Meza JL, Hermsen ED. Lack of Benefit With Combination Therapy for Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2017 05; 38(5):602-605.
-
Khalid L, Ali I, Wahid K, Khan AU, Fawad S. Purple Urine Bag Syndrome. J Coll Physicians Surg Pak. 2016 Oct; 26(10):863-864.
-
Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Pharmacotherapy. 2016 05; 36(5):463-71.
-
Albayati ZA, Sunkara M, Schmidt-Malan SM, Karau MJ, Morris AJ, Steckelberg JM, Patel R, Breen PJ, Smeltzer MS, Taylor KG, Merten KE, Pierce WM, Crooks PA. Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone. Antimicrob Agents Chemother. 2015 Dec 14; 60(3):1865-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|